Cite
Carter JH. Concerns regarding the methodology, reporting and interpretation of the therapeutic plasma exchange in multiple sclerosis randomized sham-controlled (PLASMASEP) trial. J Clin Apher. 2021;36(3):516-517doi: 10.1002/jca.21874.
Carter, J. H. (2021). Concerns regarding the methodology, reporting and interpretation of the therapeutic plasma exchange in multiple sclerosis randomized sham-controlled (PLASMASEP) trial. Journal of clinical apheresis, 36(3), 516-517. https://doi.org/10.1002/jca.21874
Carter, Jamal H. "Concerns regarding the methodology, reporting and interpretation of the therapeutic plasma exchange in multiple sclerosis randomized sham-controlled (PLASMASEP) trial." Journal of clinical apheresis vol. 36,3 (2021): 516-517. doi: https://doi.org/10.1002/jca.21874
Carter JH. Concerns regarding the methodology, reporting and interpretation of the therapeutic plasma exchange in multiple sclerosis randomized sham-controlled (PLASMASEP) trial. J Clin Apher. 2021 Jun;36(3):516-517. doi: 10.1002/jca.21874. Epub 2021 Jan 13. PMID: 33438768.
Copy
Download .nbib
